Literature DB >> 22972724

Pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections.

Jason Tan1, Christine H Smith, Ran D Goldman.   

Abstract

QUESTION: I have heard about children who have tic disorders that seem to be exacerbated by group A β-hemolytic streptococcal infection. Should children presenting with this phenomenon receive treatment with antibiotics, receive prophylactic treatment, or use immunomodulators to treat the symptoms? ANSWER: Pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections (PANDAS) constitute a condition that includes neuropsychiatric symptoms, mainly obsessive-compulsive disorder or tic disorders, temporally associated with an immune-mediated response to streptococcal infections. The actual existence of PANDAS as a unique clinical entity is still up for debate, as a temporal association between group A β-hemolytic streptococcal infections and symptom exacerbations has been difficult to prove thus far. Based on only a few studies, positive results have been found using antibiotic prophylaxis and immunomodulatory therapy in children with PANDAS. At this time, however, evidence does not support a recommendation for long-term antibiotic prophylaxis or immunomodulatory therapy.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22972724      PMCID: PMC3440267     

Source DB:  PubMed          Journal:  Can Fam Physician        ISSN: 0008-350X            Impact factor:   3.275


  15 in total

1.  PANDAS and immunomodulatory therapy.

Authors:  H S Singer
Journal:  Lancet       Date:  1999-10-02       Impact factor: 79.321

2.  The pediatric autoimmune neuropsychiatric disorders associated with streptococcal infection (PANDAS) subgroup: separating fact from fiction.

Authors:  Susan E Swedo; Henrietta L Leonard; Judith L Rapoport
Journal:  Pediatrics       Date:  2004-04       Impact factor: 7.124

3.  Association between streptococcal infection and obsessive-compulsive disorder, Tourette's syndrome, and tic disorder.

Authors:  Loren K Mell; Robert L Davis; David Owens
Journal:  Pediatrics       Date:  2005-07       Impact factor: 7.124

4.  Pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections: clinical description of the first 50 cases.

Authors:  S E Swedo; H L Leonard; M Garvey; B Mittleman; A J Allen; S Perlmutter; L Lougee; S Dow; J Zamkoff; B K Dubbert
Journal:  Am J Psychiatry       Date:  1998-02       Impact factor: 18.112

5.  Antibiotic prophylaxis with azithromycin or penicillin for childhood-onset neuropsychiatric disorders.

Authors:  Lisa A Snider; Lorraine Lougee; Marcia Slattery; Paul Grant; Susan E Swedo
Journal:  Biol Psychiatry       Date:  2005-04-01       Impact factor: 13.382

6.  Prospective identification and treatment of children with pediatric autoimmune neuropsychiatric disorder associated with group A streptococcal infection (PANDAS).

Authors:  Marie Lynd Murphy; Michael E Pichichero
Journal:  Arch Pediatr Adolesc Med       Date:  2002-04

7.  A pilot study of penicillin prophylaxis for neuropsychiatric exacerbations triggered by streptococcal infections.

Authors:  M A Garvey; S J Perlmutter; A J Allen; S Hamburger; L Lougee; H L Leonard; M E Witowski; B Dubbert; S E Swedo
Journal:  Biol Psychiatry       Date:  1999-06-15       Impact factor: 13.382

8.  Streptococcal upper respiratory tract infections and exacerbations of tic and obsessive-compulsive symptoms: a prospective longitudinal study.

Authors:  James F Leckman; Robert A King; Donald L Gilbert; Barbara J Coffey; Harvey S Singer; Leon S Dure; Heidi Grantz; Liliya Katsovich; Haiqun Lin; Paul J Lombroso; Ivana Kawikova; Dwight R Johnson; Roger M Kurlan; Edward L Kaplan
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2010-12-31       Impact factor: 8.829

9.  Therapeutic plasma exchange and intravenous immunoglobulin for obsessive-compulsive disorder and tic disorders in childhood.

Authors:  S J Perlmutter; S F Leitman; M A Garvey; S Hamburger; E Feldman; H L Leonard; S E Swedo
Journal:  Lancet       Date:  1999-10-02       Impact factor: 79.321

10.  Anti-basal ganglia antibodies in PANDAS.

Authors:  Harvey S Singer; Christopher R Loiselle; Olivia Lee; Karen Minzer; Susan Swedo; Franz H Grus
Journal:  Mov Disord       Date:  2004-04       Impact factor: 10.338

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.